Stay updated on Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Sign up to get notified when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now displayed in place of the study record, presenting the standard error message and site chrome rather than the study details.
    Difference
    17%
    Check dated 2026-09-20T00:53:08.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.5 to v3.6.6, replacing the previous revision. This reflects a minor platform update rather than changes to study details or data.
    Difference
    0.1%
    Check dated 2026-08-29T19:37:58.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.6.4 to v3.6.5, indicating a background site update; no changes to the study details are shown.
    Difference
    0.1%
    Check dated 2026-08-08T13:27:52.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a small internal update to the site's documentation or implementation.
    Difference
    0.1%
    Check dated 2026-07-25T06:26:49.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    New revision label v3.6.3 appears on the page, indicating a minor update to the page version. The study details and layout appear unchanged.
    Difference
    0.1%
    Check dated 2026-07-03T22:20:21.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The revision label now shows v3.6.2, replacing v3.6.0, indicating a backend/software update rather than a change to study information.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:25.000Z thumbnail image

Stay in the know with updates to Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.